Raymond James & Associates’s Avidity Biosciences RNA Stock Holding History

Raymond James & Associates’s Portfolio RNA Stock Details RNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$7.2M	Buy
2024 Q2	$6.28M	Sell
2024 Q1	$7.55M	Buy
2023 Q4	$1.18M	Buy
2023 Q3	$595K	Buy
2023 Q2	$925K	Buy
2023 Q1	$235K	Sell
2022 Q4	$480K	Buy
2021 Q2	–	Sell
2021 Q1	$1.08M	Buy